antibioticsbooks

310 Index
Sustained virologic response
(SVR), 245
Synercid, 125
Syphilis, 55, 108
T
Taenia, 5, 258, 270
T. solium, 269
Tapeworms, 257
Tazobactam. See also Piperacillin/
tazobactam
described, 65–68
T2 bacteriophage, 7
Teicoplanin, 93
Telaprevir, 245–248
Telavancin, described, 93–96
Telbivudine, 253
Telithromycin, described,
109–112
Tendon rupture, 98
Tenofovir (TDF), 221, 225, 228,
235–237, 253
described, 221–224
Tetracycline(s), 21, 264
antibacterial activity of, 38
classes of antibiotics, 26
described, 105–108
Thiabendazole, described,
269–271
Third-generation cephalosporins,
77–79
Threadworms, 269
Thrombocytopenia, 114, 242
Thrombotic thrombocytopenic
purpura, 208
T. gondii, 134,136, 138, 258,
265, 275
Ticarcillin/clavulanate, described,
65–68
Ticarcillin, described, 63–64
Tick-borne diseases, 107
Tigecycline, described, 105–108
Tinidazole, 258
described, 117–119
Tinnitus, 263
Tipranavir (TPV), described,
229–233
Tissue, penetration of an
antibiotic into, 27–28
TMP. See Trimethoprim (TMP)
TMP/SMX. See Trimethoprim/
sulfamethoxazole
(TMP/SMX)
Tobacco mosaic virus, 7
Tobramycin, 20
described, 101–104
Total/actual body weight, 28
Toxic epidermal necrolysis,
134, 226
Toxicities, antibiotic, 42,
134, 265
Trematodes, 257
Tremors, 208
Treponema pallidum, 54
Triamterene, 134
Trichomonas, 118
Trimethoprim (TMP), 36
hematologic adverse effects
of, 42
Trimethoprim/sulfamethoxazole
(TMP/SMX), 19, 21, 121,
123, 258, 266, 273, 274, 275
described, 133–136
susceptibility breakpoints, 36
Trizivir, 221
Trofile, 240
Tropism, 240
Truvada, 221
Trypanosoma, 258, 273
trypanosomiasis, 275
Tuberculosis, 101, 103, 104,
153–159, 163, 164
introduction to, 149–151
Tularemia, 100, 108
Typhoid fever, 136
U
Urinary tract infections (UTIs),
18, 20, 64, 82, 99–100,
107, 143
cystitis, 121–123, 135–136
pyelonephritis, 79
urosepsis, 121, 123
V
Vaccinia, 6
Vaginosis, 139
Valacyclovir, described, 207–209